InvestorsHub Logo
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Re: dcspka post# 24109

Sunday, 07/20/2014 5:27:50 PM

Sunday, July 20, 2014 5:27:50 PM

Post# of 30046
Dcspak stated: "The majority of the world needs Onko-Sure because it is fast, very effective"

You have no idea at all about cancer testing.

Onko Sure has about 50 false positives for every cancer found. That is way, way too many and the reason why it has failed in the market place.

For example another study on a lung cancer screening test had 9 false positives for every cancer found. In their studies, 130 people were found with lung cancer and 1178 had false positive results. Of the 1178, 135 of those had serious complications from additional testing. Even at that false positive rate, it was questionable if endangering the lives of so many people with false positives was worth the advantages.

The following test study has a much better false positive specificity. It is 99% for a false negative and 99.8% for false positive.

"Simple blood test can detect lung cancer with high sensitivity and specificity - results from large clinical validation study published in the Journal of Clinical Oncology"


"We have developed a minimally invasive molecular diagnostic assay that quantifies the expression of specific miRNAs which are freely circulating in blood and indicate the presence of lung cancer," stated Gabriella Sozzi, Ph.D., Professor, Head of Cancer Genomics at INT. "Overall, the results of our study support the use of the assay as a tool to improve the early detection of lung cancer."

http://www.lef.org/news/LefDailyNews.htm?NewsID=21843&Section=Disease



I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.